These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7671048)

  • 21. Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospital.
    Shen W; Wong B; Chin JY; Lee M; Coulter C; Braund R
    N Z Med J; 2016 Oct; 129(1444):90-96. PubMed ID: 27806032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bar-code technology on the incidence of medication dispensing errors and potential adverse drug events in a hospital pharmacy.
    Poon EG; Cina JL; Churchill WW; Mitton P; McCrea ML; Featherstone E; Keohane CA; Rothschild JM; Bates DW; Gandhi TK
    AMIA Annu Symp Proc; 2005; 2005():1085. PubMed ID: 16779372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2006.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2007 Mar; 64(5):507-20. PubMed ID: 17322164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication errors in inpatient pharmacy operations and technologies for improvement.
    Kuiper SA; McCreadie SR; Mitchell JF; Stevenson JG
    Am J Health Syst Pharm; 2007 May; 64(9):955-9. PubMed ID: 17468151
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmaceutical companies and unexpected drug side-effects.
    Iwarson S
    Lancet; 1985 Mar; 1(8428):580. PubMed ID: 2857929
    [No Abstract]   [Full Text] [Related]  

  • 26. Promoting rational drug use through the ASHP Commission on Therapeutics.
    Witmer DR
    Am J Hosp Pharm; 1994 Jun; 51(12):1536. PubMed ID: 8092154
    [No Abstract]   [Full Text] [Related]  

  • 27. The evolving role of the P&T committee: enhancing the health technology assessment process.
    Tadlock C
    Manag Care Interface; 2006 Feb; 19(2):14-5. PubMed ID: 16529077
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of a training program for bar-code-assisted medication administration in inpatient pharmacy.
    Dartt LR; Schneider R
    Am J Health Syst Pharm; 2010 Oct; 67(19):1592-4. PubMed ID: 20852158
    [No Abstract]   [Full Text] [Related]  

  • 29. ASHP guidelines on preventing medication errors with chemotherapy and biotherapy.
    Goldspiel B; Hoffman JM; Griffith NL; Goodin S; DeChristoforo R; Montello CM; Chase JL; Bartel S; Patel JT
    Am J Health Syst Pharm; 2015 Apr; 72(8):e6-e35. PubMed ID: 25825193
    [No Abstract]   [Full Text] [Related]  

  • 30. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Communicating adverse drug reactions.
    Lancet; 1978 Jan; 1(8056):133. PubMed ID: 87560
    [No Abstract]   [Full Text] [Related]  

  • 32. Manufacturer response to AMCP Format dossier requests.
    Lyles A; Watkins JD
    J Manag Care Pharm; 2007 Apr; 13(3):290-1; author reply 291-2. PubMed ID: 17407398
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial: The ASHP council on clinical pharmacy and therapeutics.
    Zellmer WA
    Am J Hosp Pharm; 1974 Sep; 31(9):831. PubMed ID: 4423139
    [No Abstract]   [Full Text] [Related]  

  • 34. Integrating medication management information into the online formulary at a tertiary academic medical center.
    Johnston KS; Fox ER; Beckwith MC
    Am J Health Syst Pharm; 2014 Jun; 71(12):981, 986. PubMed ID: 24865751
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug product characteristics that foster drug-use-system errors.
    Cohen MR
    Am J Health Syst Pharm; 1995 Feb; 52(4):395-9. PubMed ID: 7757867
    [No Abstract]   [Full Text] [Related]  

  • 36. The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia.
    Roughead EE; Semple SJ; Rosenfeld E
    Int J Evid Based Healthc; 2016 Sep; 14(3):113-22. PubMed ID: 26886682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacist clinical intervention program.
    Smith SR; Utterback CM; Parr DD; Waller DJ
    Top Hosp Pharm Manage; 1993 Jul; 13(2):1-15. PubMed ID: 10128810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital pharmacy services in Puerto Rico.
    Perez ME; Martinez MD; Feliu JF; Mendez CA; Garcia R
    Am J Health Syst Pharm; 2006 Mar; 63(5):460-5. PubMed ID: 16484521
    [No Abstract]   [Full Text] [Related]  

  • 39. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconciliation of medications.
    Saufl NM
    J Perianesth Nurs; 2006 Apr; 21(2):126-7. PubMed ID: 16600833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.